Background Diabetic peripheral neuropathy (DPN) is a common complication of diabetes.
Predicting the risk of developing DPN is important for clinical decision-making and …

Background Individuals with diabetes and lower-limb complications are at high risk for
cardiovascular and all-cause mortality, but uncertainties remain in terms of cancer-related …

Obesity prevalence in the US has nearly tripled since 1975 and a parallel increase in
prevalence of type 2 diabetes (T2D). Obesity promotes a myriad of metabolic derangements …

Diabetic neuropathy is one of the most common complications of diabetes. This complication
is peripheral neuropathy with predominant sensory impairment, and its symptoms begin with …

Painful diabetic neuropathy (PDN) is a devastating neurological complication of diabetes.
Methylglyoxal (MG) is a reactive metabolite whose elevation in the plasma corresponds to …

Peripheral neuropathy (PN) is a severe complication that affects over 30% of prediabetic
and 60% of type 2 diabetic (T2D) patients. The metabolic syndrome is increasingly …

Diabetic neuropathy (DN) is a devastating disorder with an increasing prevalence globally.
This epidemic can pose a critical burden on individuals and com-munities, subsequently …

Abstract Aims/Introduction Limited studies have identified risk factors linked to the
progression of diabetic peripheral neuropathy (DPN) in type 2 diabetes. This study …

OBJECTIVE To study cardiometabolic risk-factor trajectories (in terms of levels and changes
over time) preceding diabetic polyneuropathy (DPN) 13 years after a screen-detected …

Aims/hypothesis Advanced glycation end-products (AGEs) may contribute to the
development of diabetic neuropathy. In young adults with type 1 diabetes, we aimed to …